Enalapril treatment of pulmonary heart disease and Isoket Clinical efficacy of coronary heart disease.docVIP

Enalapril treatment of pulmonary heart disease and Isoket Clinical efficacy of coronary heart disease.doc

  1. 1、本文档共10页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Enalapril treatment of pulmonary heart disease and Isoket Clinical efficacy of coronary heart disease

 PAGE \* MERGEFORMAT 10 Enalapril treatment of pulmonary heart disease and Isoket Clinical efficacy of coronary heart disease Of: Zhouyong Rui, Wang Shuying, Zhao advocated Li, Zheng gravel [Abstract] Objective To observe the enalapril and the treatment of pulmonary heart disease Isoket failure of coronary heart disease. Methods chronic pulmonary heart disease 76 cases of heart failure in patients with coronary artery disease. Randomly divided into control group (38 cases) and treatment group (38 cases), the control group were given oxygen, antibiotics, expectorant, asthma, vasodilators, diuretic and other conventional treatment. the treatment group, based on a large German pharmaceutical company Schwarz injection produced Isoket 20 ~ 30mg in 5% glucose intravenous infusion of 500m1 (10 12 drops / min), day 1, 7 to 14 days for treatment, enalapril (starting dose by the Yangtze River Pharmaceutical production 5mg, 1 times / day, 7 days to 10mg, 1 times / day for 8 weeks. Detection of cardiac function and contrast the clinical symptoms. the treatment group and control group compared to the treatment group cough, phlegm, relieve asthma symptoms, LVEF had increased (P lt;0.05). Conclusions Chronic pulmonary heart disease patients with coronary heart disease and Isoket enalapril can improve heart function and improve quality of life. [Keywords:] enalapril and Isoket treatment of chronic pulmonary heart disease coronary heart disease Chronic pulmonary heart disease (Chronic pulmonary heart disease), referred to as chronic pulmonary heart disease. Atherosclerotic coronary heart disease (Coronary heart disease), referred to as coronary heart disease. These two diseases are old common disease, the two disease often coexist, our hospital and Isoket Enalapril treatment of pulmonary heart disease coronary heart disease in 38 cases, results were satisfactory, are reported below. 1 Materials and Methods 1.1 General Information Select June 2003 ~ June 2008 h

您可能关注的文档

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档